BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 16150246)

  • 1. Changing concepts in the management of differentiated thyroid cancer.
    Intenzo CM; Jabbour S; Dam HQ; Capuzzi DM
    Semin Nucl Med; 2005 Oct; 35(4):257-65. PubMed ID: 16150246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Empirically treating high serum thyroglobulin levels.
    Mazzaferri EL
    J Nucl Med; 2005 Jul; 46(7):1079-88. PubMed ID: 16000275
    [No Abstract]   [Full Text] [Related]  

  • 3. Extent of surgery for differentiated thyroid cancer.
    Dackiw AP; Zeiger M
    Surg Clin North Am; 2004 Jun; 84(3):817-32. PubMed ID: 15145237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma.
    Giovanella L; Ceriani L; Suriano S; Ghelfo A; Maffioli M
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):659-63. PubMed ID: 18363882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The importance of recombinant human thyroid stimulating hormone in the follow-up and treatment of disseminated thyroid cancer after thyroidectomy].
    Skoura E; Rontogianni P
    Hell J Nucl Med; 2007; 10(1):40-7. PubMed ID: 17450254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical management of persistent or recurrent differentiated thyroid carcinoma.
    Jun JY; Manni A
    Otolaryngol Clin North Am; 2008 Dec; 41(6):1241-60, xi-xii. PubMed ID: 19040983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and (131)I ablation.
    Salvatore B; Paone G; Klain M; Storto G; Nicolai E; D'Amico D; Della Morte AM; Pace L; Salvatore M
    Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):2-8. PubMed ID: 17538522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of follicular and Hürthle cell neoplasms of the thyroid gland.
    McHenry CR; Sandoval BA
    Surg Oncol Clin N Am; 1998 Oct; 7(4):893-910. PubMed ID: 9735140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contemporary management of papillary carcinoma of the thyroid gland.
    Rosenbaum MA; McHenry CR
    Expert Rev Anticancer Ther; 2009 Mar; 9(3):317-29. PubMed ID: 19275510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Basic policy for postsurgical follow-up of patients with differentiated thyroid carcinoma--guidelines from abroad].
    Hamada N
    Nihon Rinsho; 2007 Nov; 65(11):2061-7. PubMed ID: 18018571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hürthle cell carcinoma: a clinicopathological study of thirteen cases.
    Ozlem Küçük N; Kulak H; Tokmak E; Tar P; Ibiş E; Aras G
    Nucl Med Commun; 2006 Apr; 27(4):377-9. PubMed ID: 16531925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Taking of position in relationship to the protocol of the current treatment of thyroid nodules and differentiated thyroid cancer].
    Gómez Sáez JM
    Endocrinol Nutr; 2010 Oct; 57(8):370-5. PubMed ID: 20850397
    [No Abstract]   [Full Text] [Related]  

  • 13. The evolving role of (131)I for the treatment of differentiated thyroid carcinoma.
    Robbins RJ; Schlumberger MJ
    J Nucl Med; 2005 Jan; 46 Suppl 1():28S-37S. PubMed ID: 15653649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Differentiated thyroid cancer].
    Tiedje V; Schmid KW; Weber F; Bockisch A; Führer D
    Internist (Berl); 2015 Feb; 56(2):153-66; quiz 167-8. PubMed ID: 25627410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroglobulin: a specific serum marker for the management of thyroid carcinoma.
    Whitley RJ; Ain KB
    Clin Lab Med; 2004 Mar; 24(1):29-47. PubMed ID: 15157556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Papillary thyroid cancer: monitoring and therapy.
    Tuttle RM; Leboeuf R; Martorella AJ
    Endocrinol Metab Clin North Am; 2007 Sep; 36(3):753-78, vii. PubMed ID: 17673127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Follow-up care for differentiated thyroid cancer].
    Hüfner M; Reiners C
    Dtsch Med Wochenschr; 1986 Nov; 111(45):1732-4. PubMed ID: 3536387
    [No Abstract]   [Full Text] [Related]  

  • 18. Current issues in the management of differentiated thyroid cancer.
    Mallick UK; Charalambous H
    Nucl Med Commun; 2004 Sep; 25(9):873-81. PubMed ID: 15319591
    [No Abstract]   [Full Text] [Related]  

  • 19. [Diagnosis, treatment and follow-up in the case of differentiated thyroid cancer].
    Lind P; Igerc I; Kohlfürst S
    Wien Med Wochenschr; 2005 Oct; 155(19-20):429-35. PubMed ID: 16424998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid cancer: an overview.
    Haq M; Harmer C
    Nucl Med Commun; 2004 Sep; 25(9):861-7. PubMed ID: 15319589
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.